Enlivex Therapeutics Ltd. is a clinical-stage pharmaceutical company focused on macrophage reprogramming with a goal of developing affordable, off-the-shelf cell therapies for difficult-to-treat life-threatening diseases, such as solid cancers and Sepsis, that have no good solutions today.
